Latest From Biotech Now

Patients Remain the Focus for the Future of Personalizing Oncology

lab_tech02

The 17th Annual BIO CEO & Investor Conference, being held at the Waldorf Astoria in New York City, kicked off this morning with an interactive panel of industry heavyweights discussing the growing trend to personalize oncology treatments with molecular diagnostics. Moderated by Michael King, Managing Director, Senior Research Analyst, JMP Securities. Michael helped steer the group of experts as they discussed enabling broader matching of patient-cancer-therapy, lessons learned from the Cancer Genome Atlas and the potential Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Dow Jones VentureWire: BIO Report on Venture Funding for Therapeutic Innovation

lab_tech

Today, Brian Gormley’s story – Biotech VCs Shift Away From Chronic Diseases, Report Says – highlights VC funding trends over a 10-year period. BIO released the report today showing that venture capital is shifting away from chronic diseases and increasing for rare diseases. The report categorized $38 billion of investment across more than 1,200 companies from 2004 through 2013. BIO’s report compares five-year periods before and after the financial crisis. From 2004 through 2008, for Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

National Black HIV/AIDS Awareness Day

National Black HIV/AIDS Awareness Day

In the United States, more than one million people are infected with HIV, with an estimated 50,000 newly diagnosed each year. While African Americans make up only 12-14 percent of the U.S. population they account for nearly half (44 percent) of all the new HIV infections in the U.S. (CDC). Today, as the United States observes National Black HIV/AIDS Awareness Day, we’d like to take a look at some of the scientific advancements made in Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Unleashing the Full Promise of Biotechnology Innovation

Jim Greenwood

Last week, I attended the announcement of President Obama’s Precision Medicine Initiative at the White House. In the room were leading biotechnology executives, researchers, lawmakers from both parties, regulatory officials and patients. Seated just a few rows in front of me was a young man named Bill Elder whose life has been transformed by a cystic fibrosis drug developed by one of our member companies, Vertex. Today, Bill is a third-year medical student with an Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

Does a “non-G.M.O” Label Really Mean without GMOs?

Non gmo verfieid

In her article, Many G.M.O.-Free Labels, Little Clarity Over Rules, Stephanie Strom examines the issues behind food manufacturers adding the phrase “non-G.M.O.” to their packaging without having to go through a verification process: So if more companies elect to put labels on their products stating that they are G.M.O.-free, whether verified or not, does that make the fierce policy debate increasingly moot? “It’s an interesting question,” said Jean Halloran, director of food policy initiatives at Consumers Union, which lobbies Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,